Roflumilast: first phosphodiesterase 4 inhibitor approved for treatment of COPD

Overview of attention for article published in Drug Design, Development and Therapy, July 2010

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (71st percentile)

Mentioned by

policy: 1 policy source

patent: 1 patent

Citations

dimensions_citation: 120 Dimensions

Readers on

mendeley: 97 Mendeley

Summary Policy documents Patents Dimensions citations

So far, Altmetric has seen 1 patent that references this research output.

Compositions and methods for treating otitis media and other conditions with inhibitors…

Grant US-9951335-B2

United States of America